Favorable response to PD-1 receptor inhibitor pembrolizumab as a third-line therapy in ROS1-rearranged advanced lung cancer: A case report and review of the literature
| Autor: | Chaudhry, Akriti, Schuppe, Kyle, Burke, Skyler, Lobova, Veronika, Seigel, Quincy, Kirby, Carsten, Chitlik, Sara, Andrei, Mirela, Kaya, Erin |
|---|---|
| Zdroj: | In Current Problems in Cancer: Case Reports December 2022 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|